Poster Session 2
Category: Epidemiology
Poster Session 2
James D. Toppin, MD, MPH
Fellow
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
Talia Suner, MD
Maternal Fetal Medicine Fellow
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
Brian James, MD
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
Joseph R. Biggio, Jr., MD (he/him/his)
System Chair, Women's Services
Ochsner Health
New Orleans, Louisiana, United States
Frank B. Williams, MD, MPH (he/him/his)
Ochsner Clinic Foundation
Ochsner Clinic Foundation, Louisiana, United States
The COVID-19 pandemic represented a disruption event in vaccination uptake, with shifting public sentiment on vaccination. We sought to examine the association between maternal Tdap refusal and neonatal hepatitis B vaccine refusal while assessing rural-urban geographic disparities in vaccination.
Study Design:
We performed a retrospective analysis of 103,549 mother-infant pairs from 2016 to 2024 undergoing prenatal and delivery care at a large regional health system in the American South. Multivariable logistic regression was used to assess maternal Tdap refusal as a predictor of neonatal hepatitis B refusal, controlling for insurance, age, delivery year, and COVID-19 period. Rural-Urban Commuting Area (RUCA) codes were used to stratify populations into urban, large rural, small rural, and isolated rural categories. Adjusted odds ratios (aOR) with 95% confidence intervals (CI) were generated.
Results:
The mean patient age was 28.4 years (SD 5.8), 60.3% public insurance, and 41.1% Black. RUCA categorization from urban to most rural was 88.4%, 7.6%, 3.3%, and 0.7%, respectively. Overall maternal Tdap, neonatal hepatitis B, and concordant vaccination rates were 56.4%, 85.9%, and 61.9%, respectively. Maternal Tdap refusal strongly predicted neonatal hepatitis B refusal (aOR 3.13, 95% CI 3.02, 3.25). Substantial rural-urban vaccination rate disparities were found, with urban areas achieving the highest concordant maternal-neonatal vaccination rates at 53.7%, while rural areas demonstrated significantly lower rates: large rural 33.9%, small rural 38.7%, and isolated rural 35.6%. Maternal Tdap vaccination rates showed the largest geographic disparities, ranging from 58.8% in urban areas to 37.3% in large rural areas. Neonatal hepatitis B vaccination rates were more geographically consistent, but still showed urban advantages.
Conclusion:
Maternal vaccination strongly predicts neonatal vaccine acceptance, with pronounced rural-urban disparities in vaccination coordination. These findings highlight the need for targeted interventions in rural areas to improve both maternal and neonatal vaccination rates.